Adrienne Phillips, MD, MPH, has been selected to receive the ASH-AMFDP Award to conduct research on HLTV-1 adult T-cell leukemia/lymphoma. The award, designed to help increase the number of underrepresented minority scholars in the field of hematology, is the result of a partnership between the American Society of Hematology (ASH) and the Harold Amos Medical Faculty Development Program (AMFDP) of the Robert Wood Johnson Foundation. It provides four years of support, including an annual stipend of up to $75,000 and an annual grant of $30,000 to support research activities.

"I was thrilled and honored to be the recipient of the ASH-AMFDP award for 2011," said Dr. Phillips. "This award represents an outstanding career development opportunity for which I am tremendously grateful. The support provided by ASH and AMFDP will give me protected time, funding, and career counseling that will advance my research and support my development as an academic hematologist."

Dr. Phillips, Assistant Professor of Clinical Medicine, Division of Hematology/Oncology at Columbia University, College of Physicians and Surgeons, will explore the effect of an immunomodulatory agent as part of a phase II clinical trial in patients with relapsed or refractory HTLV-1-related adult T-cell leukemia/lymphoma. The results from her research may help to identify mechanisms of leukemogenesis and further efforts in the development of experimental therapeutics for patients with this fatal disease.

Dr. Phillips received her medical degree from Brown University in Providence, RI, and completed her residency at New York Presbyterian Hospital.

Source:
American Society of Hematology